Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Still no takers

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Nov 27, 2024 4:05pm

74 Views

Post# 36334379

RE:RE:RE:RE:Still no takers

No idea I mean they aren't even using their "strongest compound" TLD 1633 combined with transferrin instead they are going with TLD 1433 and transferrin and of course it's always "subject to funding" while everyone keeps getting their yearly option bonuses.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing